Peroxisome proliferator-activated receptor-γ-mediated polarization of macrophages in leishmania infection

PPAR Research

Volumn , Issue , 2012, Pages

  Chan, Marion M ^a   Adapala, Nagasuresh ^a   Chen, Cui ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Temple University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

HOST PARASITE INTERACTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA DONOVANI; LEISHMANIASIS; MACROPHAGE; NONHUMAN; PARASITE VIRULENCE; PROTEIN EXPRESSION; REVIEW;

EID: 84863392710     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2012/796235     Document Type: Review

References (47)

1. Kedzierski L., Sakthianandeswaren A., Curtis J. M., Andrews P. C., Junk P. C., Kedzierska K., Leishmaniasis: current treatment and prospects for new drugs and vaccines Current Medicinal Chemistry 2009 16 5 599 614
2. Heinzel F. P., Sadick M. D., Holaday B. J., Coffman R. L., Locksley R. M., Reciprocal expression of interferon or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets Journal of Experimental Medicine 1989 169 1 59 72 (Pubitemid 19035542)
3. Nylén S., Gautam S., Immunological perspectives of leishmaniasis Journal of Global Infectious Diseases 2010 2 135 146
4. Ji J., Masterson J., Sun J., Soong L., CD4 + CD25 + regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection Journal of Immunology 2005 174 11 7147 7153 (Pubitemid 40705681)
5. Chatelain R., Mauze S., Coffman R. L., Experimental Leishmania major infection in mice: role of IL-10 Parasite Immunology 1999 21 4 211 218 (Pubitemid 29158767)
6. Sacks D., Anderson C., Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice Immunological Reviews 2004 201 225 238 (Pubitemid 39318455)
7. Guimares E. T., Santos L. A., Ribeiro dos Santos R., Teixeira M. M., dos Santos W. L. C., Soares M. B. P., Role of interleukin-4 and prostaglandin E2 in Leishmania amazonensis infection of BALB/c mice Microbes and Infection 2006 8 5 1219 1226 (Pubitemid 43842002)
8. Chatelain R., Mauze S., Varkila K., Coffman R. L., Leishmania major infection in interleukin-4 and interferon- depleted mice Parasite Immunology 1999 21 8 423 431 (Pubitemid 29353967)
9. Alexander J., McFarlane E., Can type-1 responses against intracellular pathogens be T helper 2 cytokine dependent? Microbes and Infection 2008 10 9 953 959
10. Martinez F. O., Helming L., Gordon S., Alternative activation of macrophages: an immunologic functional perspective Annual Review of Immunology 2009 27 451 483
11. Munder M., Eichmann K., Modolell M., Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4 + T cells correlates with Th1/Th2 phenotype Journal of Immunology 1998 160 11 5347 5354 (Pubitemid 28267823)
12. Chawla A., Control of macrophage activation and function by PPARs Circulation Research 2010 106 10 1559 1569
13. Gallardo-Soler A., Gmez-Nieto C., Campo M. L., Marathe C., Tontonoz P., Castrillo A., Corraliza I., Arginase I induction by modified lipoproteins in macrophages: a peroxisome proliferator-activated receptor- / -mediated effect that links lipid metabolism and immunity Molecular Endocrinology 2008 22 6 1394 1402 (Pubitemid 351786999)
14. Rios F. J. O., Jancar S., Melo I. B., Ketelhuth D. F. J., Gidlund M., Role of PPAR-gamma in the modulation of CD36 and FcgammaRII induced by LDL with low and high degrees of oxidation during the differentiation of the monocytic THP-1 cell line Cellular Physiology and Biochemistry 2008 22 5-6 549 556
15. Ricote M., Welch J. S., Glass C. K., Regulation of macrophage gene expression by the peroxisome proliferator-activated receptor- Hormone Research 2000 54 5-6 275 280 (Pubitemid 34701733)
16. Adapala N., Chan M. M., Long-term use of an antiinflammatory, curcumin, suppressed type 1 immunity and exacerbated visceral leishmaniasis in a chronic experimental model Laboratory Investigation 2008 88 12 1329 1339
17. Titus R. G., Marchand M., Boon T., Louis J. A., A limiting dilution assay for quantifying Leishmania major in tissues of infected mice Parasite Immunology 1985 7 5 545 555 (Pubitemid 16256170)
18. Reiner N. E., Malemud C. J., Arachidonic acid metabolism in murine leishmaniasis (Donovani): ex-vivo evidence for increased cyclooxygenase and 5-lipoxygenase activity in spleen cells Cellular Immunology 1984 88 2 501 510 (Pubitemid 15200457)
19. Reiner N. E., Malemud C. J., Arachidonic acid metabolism by murine peritoneal macrophages infected with Leishmania donovani: in vitro evidence for parasite-induced alterations in cyclooxygenase and lipoxygenase pathways Journal of Immunology 1985 134 1 556 563 (Pubitemid 15191551)
20. Lonardoni M. V. C., Barbieri C. L., Russo M., Jancar S., Modulation of Leishmania (L.) amazonensis growth in cultured mouse macrophages by prostaglandins and platelet activating factor Mediators of Inflammation 1994 3 2 137 141 (Pubitemid 24131930)
21. Cuzzocrea S., Wayman N. S., Mazzon E., Dugo L., Paola R. D., Serraino I., Britti D., Chatterjee P. K., Caputi A. P., Thiemermann C., The cyclopentenone prostaglandin 15-deoxy- 12,14 -prostaglandin J 2 attenuates the development of acute and chronic inflammation Molecular Pharmacology 2002 61 5 997 1007 (Pubitemid 34441764)
22. Ribeiro-Gomes F. L., Otero A. C., Gomes N. A., Moniz-De-Souza M. C. A., Cysne-Finkelstein L., Arnholdt A. C., Calich V. L., Coutinho S. G., Lopes M. F., DosReis G. A., Macrophage interactions with neutrophils regulate leishmania major infection Journal of Immunology 2004 172 7 4454 4462 (Pubitemid 38375261)
23. Bonnans C., Fukunaga K., Levy M. A., Levy B. D., Lipoxin A 4 regulates bronchial epithelial cell responses to acid injury American Journal of Pathology 2006 168 4 1064 1072
24. Chan M. M. Y., Moore A. R., Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production Journal of Immunology 2010 184 11 6418 6426
25. Bannenberg G., Serhan C. N., Specialized pro-resolving lipid mediators in the inflammatory response: an update Biochimica et Biophysica Acta 2010 1801 12 1260 1273
26. Wenzel A., Van Zandbergen G., Lipoxin A4 receptor dependent leishmania infection Autoimmunity 2009 42 4 331 333
27. El Kebir D., Filep J. G., Role of neutrophil apoptosis in the resolution of inflammation TheScientificWorldJournal 2010 10 1731 1748
28. Wanderley J. L. M., Moreira M. E. C., Benjamin A., Bonomo A. C., Barcinski M. A., Mimicry of apoptotic cells by exposing phosphatidylserine participates in the establishment of amastigotes of Leishmania (L) amazonensis in mammalian hosts Journal of Immunology 2006 176 3 1834 1839 (Pubitemid 43134328)
29. Savill J., Hogg N., Haslett C., Macrophage vitronectin receptor, CD36, and thrombospondin cooperate in recognition of neutrophils undergoing programmed cell death Chest 1991 99 supplement 3 6S 7S
30. Van Zandbergen G., Klinger M., Mueller A., Dannenberg S., Gebert A., Solbach W., Laskay T., Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages Journal of Immunology 2004 173 11 6521 6525 (Pubitemid 39541033)
31. Peters N. C., Egen J. G., Secundino N., Debrabant A., Kimblin N., Kamhawi S., Lawyer P., Fay M. P., Germain R. N., Sacks D., In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies Science 2008 321 5891 970 974
32. Van Zandbergen G., Bollinger A., Wenzel A., Kamhawi S., Voll R., Klinger M., Mller A., Hlscher C., Herrmann M., Sacks D., Solbach W., Laskay T., Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum Proceedings of the National Academy of Sciences of the United States of America 2006 103 37 13837 13842 (Pubitemid 44413994)
33. Noben-Trauth N., Kropf P., Mller I., Susceptibility to Leishmania major infection in interleukin-4-deficient mice Science 1996 271 5251 987 990 (Pubitemid 26066396)
34. Doggrell S., Do peroxisome proliferation receptor- antagonists have clinical potential as combined antiobesity and antidiabetic drugs? Expert Opinion on Investigational Drugs 2003 12 4 713 716 (Pubitemid 36512014)
35. Liu J., Wu X., Mitchell B., Kintner C., Ding S., Schultz P. G., A small-molecule agonist of the Wnt signaling pathway Angewandte Chemie 2005 44 13 1987 1990 (Pubitemid 40483016)
36. Soller M., Tautenhahn A., Brne B., Zacharowski K., John S., Link H., Von Knethen A., Peroxisome proliferator-activated receptor contributes to T lymphocyte apoptosis during sepsis Journal of Leukocyte Biology 2006 79 1 235 243 (Pubitemid 43054269)
37. Odegaard J. I., Ricardo-Gonzalez R. R., Goforth M. H., Morel C. R., Subramanian V., Mukundan L., Eagle A. R., Vats D., Brombacher F., Ferrante A. W., Chawla A., Macrophage-specific PPAR controls alternative activation and improves insulin resistance Nature 2007 447 7148 1116 1120 (Pubitemid 47014427)
38. Martin H., Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components Mutation Research 2010 690 1-2 57 63
39. Chan M. M. Y., Adapala N. S., Fong D., Curcumin overcomes the inhibitory effect of nitric oxide on Leishmania Parasitology Research 2005 96 1 49 56 (Pubitemid 40674924)
40. Chan M. M. Y., Huang H. I., Fenton M. R., Fong D., In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties Biochemical Pharmacology 1998 55 12 1955 1962 (Pubitemid 28477465)
41. Jacob A., Wu R., Zhou M., Wang P., Mechanism of the anti-inflammatory effect of curcumin: PPAR- activation PPAR Research 2007 2007
42. Kang Q., Chen A., Curcumin suppresses expression of low-density lipoprotein (LDL) receptor, leading to the inhibition of LDL-induced activation of hepatic stellate cells British Journal of Pharmacology 2009 157 8 1354 1367
43. Lin J., Chen A., Activation of peroxisome proliferator-activated receptor- by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells Laboratory Investigation 2008 88 5 529 540 (Pubitemid 351581455)
44. Zheng S., Chen A., Disruption of transforming growth factor- signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor- in rat hepatic stellate cells American Journal of Physiology 2007 292 1 G113 G123
45. Nicolas L., Prina E., Lang T., Milon G., Real-time PCR for detection and quantitation of Leishmania in mouse tissues Journal of Clinical Microbiology 2002 40 5 1666 1669 (Pubitemid 34493137)
46. Chan M. M., Evans K. W., Moore A. R., Fong D., Peroxisome proliferator-activated receptor (PPAR): balance for survival in parasitic infections Journal of biomedicine amp; biotechnology 2010 2010 828951
47. Chawla A., Control of macrophage activation and function by PPARs Circulation Research 2010 106 10 1559 1569